2020
DOI: 10.1007/s00439-020-02217-4
|View full text |Cite
|
Sign up to set email alerts
|

Special issue on “Feto-Maternal Genomic Medicine”: a decade of incredible advances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 8 publications
0
7
0
Order By: Relevance
“…Previous genetic studies of pregnancy losses are limited for several reasons, including (1) lack of access to paternal DNA samples, which would make interpretations difficult without distinguishing inherited form from de novo variants, 30 (2) unavailability of pedigrees with products of conception from chromosomally normal losses and live-births, or (3) unavailability of high-quality data and protocols for DNA restoration and variant detection. [31][32][33] Loss-of-function risk variants and inherited variants in intolerant genes (i.e., genes that are critical for human development, conditions incompatible with life resulting in fetal demise) 16,23,34 were not identified, possibly due to limited sample size and focus on families with recurrent, rather than sporadic losses.…”
Section: Discussionmentioning
confidence: 99%
“…Previous genetic studies of pregnancy losses are limited for several reasons, including (1) lack of access to paternal DNA samples, which would make interpretations difficult without distinguishing inherited form from de novo variants, 30 (2) unavailability of pedigrees with products of conception from chromosomally normal losses and live-births, or (3) unavailability of high-quality data and protocols for DNA restoration and variant detection. [31][32][33] Loss-of-function risk variants and inherited variants in intolerant genes (i.e., genes that are critical for human development, conditions incompatible with life resulting in fetal demise) 16,23,34 were not identified, possibly due to limited sample size and focus on families with recurrent, rather than sporadic losses.…”
Section: Discussionmentioning
confidence: 99%
“…For studies that did not report specific pathways, we conducted an Online Mendelian Inheritance in Man (OMIM) search to identify the roles of the reported genes in disease or functional pathways. Finally, we focused our discussion toward studies that report findings based on genetic factors that are likely causal (e.g., single-gene, autosomal and/or recessive de novo or inherited mutations, "intolerome, " copy number variations [CNVs], single nucleotide polymorphisms [SNPs]) (13). We summarized multiomic studies, e.g., studies based on proteins and methylated genes that have different mechanisms than single-gene mutations or CNVs.…”
Section: Study Summarizationmentioning
confidence: 99%
“…In these databases, lethal phenotypes are especially poorly represented. Other strategies for gene discovery, including determination of the "intolerome" are likely to reveal new genotype-phenotype correlations and shed light on the human "intolerome, " conditions incompatible with life resulting in fetal demise (11,13). Studies that incorporate DNA sequencing in affected and unaffected families, designed as case-control trio studies, will help in determination of the "intolerome" by identifying novel embryonic-lethal or fetal-lethal variants that are not seen in unaffected families.…”
Section: Guide To Next Steps In Determining Genetic Factors Associated With Pregnancy Lossmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, detection rate for all congenital cardiac malformations using ultrasound is only a 36 to 39%. 8 As chromosomal microarray assessments aid standard genetic testing for perinatal diagnoses, 9 identifying pathogenic CNVs associated with fetal structural malformations can guide the management and counseling of families at risk for stillbirth. As such, information about the likelihood of associated anomalies that are not apparent in the second trimester may inform important medical decisions.…”
Section: Introductionmentioning
confidence: 99%